TP53 and nasopharyngeal carcinoma: Therefore, circRNA-0067717 increased the resistance of NPC cells to paclitaxel treatment by acting as a scaffold for TRIM41 and p53 and promoting TRIM41-mediated p53 degradation through ubiquitination.